Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2009 1
2011 3
2012 1
2013 1
2014 2
2016 4
2017 3
2018 4
2019 7
2020 8
2021 6
2022 4
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.
Rheault MN, Alpers CE, Barratt J, Bieler S, Canetta P, Chae DW, Coppock G, Diva U, Gesualdo L, Heerspink HJL, Inrig JK, Kirsztajn GM, Kohan D, Komers R, Kooienga LA, Lieberman K, Mercer A, Noronha IL, Perkovic V, Radhakrishnan J, Rote W, Rovin B, Tesar V, Trimarchi H, Tumlin J, Wong MG, Trachtman H; DUPRO Steering Committee and DUPLEX Investigators. Rheault MN, et al. N Engl J Med. 2023 Dec 28;389(26):2436-2445. doi: 10.1056/NEJMoa2308550. Epub 2023 Nov 3. N Engl J Med. 2023. PMID: 37921461 Clinical Trial.
At the time of the final analysis at week 108, there were no significant between-group differences in the eGFR slope; the between-group difference in total slope (day 1 to week 108) was 0.3 ml per minute per 1.73 m(2) of body-surface area per year (95% confidence interval …
At the time of the final analysis at week 108, there were no significant between-group differences in the eGFR slope; the between-group diff …
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.
Lorusso D, Colombo N, Herraez AC, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay SE, Ray-Coquard IL, Shapira-Frommer R, Kim YM, McCormack M, Massaad R, Nguyen AM, Zhao Q, McKenzie J, Prabhu VS, Makker V. Lorusso D, et al. Eur J Cancer. 2023 Jun;186:172-184. doi: 10.1016/j.ejca.2023.03.015. Epub 2023 Mar 23. Eur J Cancer. 2023. PMID: 37086595 Free PMC article. Clinical Trial.
PATIENTS AND METHODS: Patients were randomly assigned to receive LEN+PEMBRO (n = 411; LEN 20 mg/day; PEMBRO 200 mg Q3W) or TPC (n = 416; doxorubicin 60 mg/m(2) Q3W or paclitaxel 80 mg/m(2) [weekly, 3 weeks on/1 week off]). ...
PATIENTS AND METHODS: Patients were randomly assigned to receive LEN+PEMBRO (n = 411; LEN 20 mg/day; PEMBRO 200 mg Q3W) or TPC (n = 416; dox …
"Anosognosia for prospective and retrospective memory deficits: Assessment and theoretical considerations": Correction to Chapman et al. (2019).
[No authors listed] [No authors listed] Neuropsychology. 2021 Sep;35(6):668. doi: 10.1037/neu0000752. Epub 2021 May 13. Neuropsychology. 2021. PMID: 33983762
The aim of this study is to elucidate how to best conceptualize and detect anosognosia for memory loss by introducing a new method of assessment, the Visual-Analogue Test for Anosognosia for memory impairment (VATAmem). Method: A total of 51 patients (M = 61 years, M …
The aim of this study is to elucidate how to best conceptualize and detect anosognosia for memory loss by introducing a new method of assess …
Reply to P.-H. Luo et al.
Monk BJ, Colombo N, Tewari KS, Tekin C, Keefe SM, Lorusso D. Monk BJ, et al. J Clin Oncol. 2024 Mar 7:JCO2400077. doi: 10.1200/JCO.24.00077. Online ahead of print. J Clin Oncol. 2024. PMID: 38452314 No abstract available.
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology.
De Angelis R, Ferri C, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Riccieri V, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano AM, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Cipolletta E, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Pellagrino G, Pigatto E, Lazzaroni MG, Franceschini F, Generali E, Mennillo G, Barsotti S, Mariano GP, Furini F, Vultaggio L, Parisi S, Peroni CL, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Guiducci S, Doria A, Salvarani C, Iannone F, Matucci-Cerinic M; SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology). De Angelis R, et al. RMD Open. 2023 Mar;9(1):e002890. doi: 10.1136/rmdopen-2022-002890. RMD Open. 2023. PMID: 36868782 Free PMC article.
RESULTS: Among patients with SSc, only 61 (3.4%) were classified as having ssSSc (F/M=19/1). Time from Raynaud's phenomenon (RP) onset to diagnosis was longer in ssSSc (3 years, IQR 1-16.5) than lcSSc (2 years, IQR 0-7), and dcSSc (1 year, IQR 0-3) (p<0.001). ...
RESULTS: Among patients with SSc, only 61 (3.4%) were classified as having ssSSc (F/M=19/1). Time from Raynaud's phenomenon (RP) onse …
Pianeta Nutrizione kids: international pediatric conference on food, physical activity, growth and well-being : Milan, Italy. 25-27 June 2015.
Agosti M, Agostoni C, Chalons S, Chavatte-Palmer P, Villares JMM, Nicklaus S, Pereira-da-Silva L, Pietrobelli A; the MeNu Group; Rolland-Cachera MF, Zuccotti GV, Cappa M, Caruso-Nicoletti M, Inzaghi E, Cianfarani S, De Curtis M, Guazzarotti L, Iughetti L, Chiarelli F, Comegna L, Franchini S, Perrone L, Umano GR, Petrella E, Bruno R, Bertarini V, Pedrielli G, Neri I, Facchinetti F, Prodam F, Sartorio A, Buckler JMH, Marazzi N, Street ME, Patianna VD, Accorsi P, Scocco SL, Amarri S, Pellai A, Merati G, Merzagora I, Rampichini S, Veicsteinas A, Clerici M, Manzoni P, Tavella E, Boano E, Farina D, Pace F. Agosti M, et al. Ital J Pediatr. 2016 Jun 6;42 Suppl 1(Suppl 1):53. doi: 10.1186/s13052-016-0240-0. Ital J Pediatr. 2016. PMID: 27294377 Free PMC article.
A1 Preterm and low birth weight nutrition in the first month life: implications for the outcome Massimo Agosti A2 Behind human milk and breastfeeding: not only food, not only growth Carlo Agostoni A3 To prevent obesity: importance and issues of cultural adaptation from weaning to …
A1 Preterm and low birth weight nutrition in the first month life: implications for the outcome Massimo Agosti A2 Behind human milk and brea …
Plasma activated water triggers plant defence responses.
Zambon Y, Contaldo N, Laurita R, Várallyay E, Canel A, Gherardi M, Colombo V, Bertaccini A. Zambon Y, et al. Sci Rep. 2020 Nov 5;10(1):19211. doi: 10.1038/s41598-020-76247-3. Sci Rep. 2020. PMID: 33154510 Free PMC article.
Microbial activity in alpine soils under climate change.
D'Alò F, Odriozola I, Baldrian P, Zucconi L, Ripa C, Cannone N, Malfasi F, Brancaleoni L, Onofri S. D'Alò F, et al. Sci Total Environ. 2021 Aug 20;783:147012. doi: 10.1016/j.scitotenv.2021.147012. Epub 2021 Apr 10. Sci Total Environ. 2021. PMID: 33872894
Two sites at two different elevations were chosen, a subalpine (2239 m) and an alpine belt (2604-2624 m), with mean annual air temperature differing by almost 3 C, coherent with the worst future warming scenario (RCP 8.5) by 2100. ...
Two sites at two different elevations were chosen, a subalpine (2239 m) and an alpine belt (2604-2624 m), with mean annual air …
57 results